Friday 6 November 2026 Export NBIX’s income statement to Excel — free account

Neurocrine Biosciences, Inc.

NBIX Healthcare Drug Manufacturers Specialty & Generic

Neurocrine Biosciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 21.4% from fiscal 2024.

Revenue: +41.2%
EPS: −3.67%
Free cash flow: +79.0%

Quarter to September 2026, against a year earlier

164.51 4.75 +2.97%

Follow NBIX

Alert me

Market cap: $16.2B
P/E: 23.6×
Fwd P/E: 20.6×
Dividend yield: —
F-score: 7/9
Altman Z: 7.80
Beneish M: −2.64
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	6	6	7	7	+8 more TTM periods Free account
ROE Full definition →	20.41%	22.09%	22.50%	16.38%
ROA Full definition →	14.20%	15.26%	15.56%	11.46%
ROIC Full definition →	17.65%	15.04%	23.58%	21.83%
Return on Tangible Assets Full definition →	62.96%	82.66%	39.44%	25.61%
Average Days of Receivables Full definition →	94.39	95.96	90.37	87.64
Free Cash Flow per Share Full definition →	10.23	8.62	8.27	7.52
Free Cash Flow Full definition →	1,039.70	870.40	831.30	748.70
Capital Expenditures Full definition →	(26.10)	(27.70)	(32.40)	(34.00)
Other line items
Cash ROIC Full definition →	22.52%	21.32%	17.60%	15.82%
Accounts Receivable Turnover Full definition →	4.39	4.55	4.83	4.91
Accounts Payable Turnover Full definition →	0.11	0.11	0.09	0.09
Inventory Turnover Full definition →	1.21	0.86	0.92	0.82
Average Days of Payables Full definition →	4,100.26	4,238.93	4,976.10	4,723.98
Days of Inventory on Hand Full definition →	293.51	546.45	415.21	483.40
Tax Rate Full definition →	(0.25)	(0.25)	(0.29)	(0.32)
Research and Development Expense of Revenue Full definition →	33.31%	33.52%	33.80%	35.51%
Selling, General and Administrative Expense of Revenue Full definition →	38.53%	40.06%	38.62%	40.42%
Share Based Compensation of Revenue Full definition →	6.35%	6.95%	7.17%	7.62%
Interest Coverage Full definition →	113.73	92.42	—	—
Operating CF/Net income Full definition →	1.52	1.27	1.29	1.64
Depreciation/Fixed assets Full definition →	0.85	0.42	0.19	0.19
Capex/Depreciation Full definition →	(0.33)	(0.74)	(1.89)	(1.95)
Revenue per Share Full definition →	36.43	33.41	30.87	28.75
Operating CF per Share Full definition →	10.49	8.89	8.59	7.87
Capex per Share Full definition →	(0.26)	(0.27)	(0.32)	(0.34)
Capex to Sales Full definition →	0.01	0.01	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly